Altorjay Aron, Paal Balazs, Sohar Nicolette, Kiss Janos, Szanto Imre, Sohar Istvan
Department of Surgery, Saint George University Teaching Hospital, Seregélyesi u. 3., Székesfehérvár, H-8000, Hungary.
World J Gastroenterol. 2005 Oct 7;11(37):5751-6. doi: 10.3748/wjg.v11.i37.5751.
To establish whether there are fundamental differences in the biochemistries of adenocarcinomas of the gastroesophageal junction (GEJ) and the squamous cell carcinomas of the lower third of the esophagus (LTE).
Between February 1, 1997 and February 1, 2000, we obtained tissue samples at the moment of resection from 54 patients for biochemical analysis. The full set of data could be comprehensively analyzed in 47 of 54 patients samples (81%). Of these, 29 were adenocarcinomas of the GEJ Siewert type I (n = 8), type II (n = 12), type III (n = 9), and 18 presented as squamous cell carcinomas of the LTE. We evaluated the mean values of 11-lysosomal enzyme and 1-cytosol protease activities of the tumorous and surrounding mucosae as well as their relative activities, measured as the ratio of activity in tumor and normal tissues from the same patient. These data were further analyzed to establish the correlation with tumor localization, TNM stage (lymph-node involvement), histological type (papillary, signet-ring cell, tubular), state of differentiation (good, moderate, poor), and survival (<or=24 or >or=24 mo).
In adenocarcinomas, the activity of alpha-mannosidase (AMAN), cathepsin B (CB) and dipeptidyl-peptidase I (DPP I) increased significantly as compared to the normal gastric mucosa. In squamous cell carcinomas of the esophagus, we also found a significant difference in the activity of cathepsin L and tripeptidyl-peptidase I in addition to these three. There was a statistical correlation of AMAN, CB, and DPP I activity between the level of differentiation of adenocarcinomas of the GEJ and lymph node involvement, because tumors with no lymph node metastases histologically confirmed as well-differentiated, showed a significantly lower activity. The differences in CB and DPP I activity correlated well with the differences in survival rates, since the CB and DPP I values of those who died within 24 mo following surgical intervention were significantly higher than of those who survived for 2 years or more.
Adenocarcinomas of the GEJ form a homogenous group from a tumor-biochemical aspect, and differ from the biochemical characteristics of squamous cell carcinomas of the LTE on many points. When adenocarcinomas of the GEJs are examined at the preoperative phase, the ratio of the performed AMAN, CB, and DPP I enzymatic activity of the tissue sample from the tumor and adjacent intact mucosa within 2 cm of the tumor may have a prognostic value even in the preoperative examination period, and may indicate that ranking of these patients into the neo-adjuvant treatment group should be considered.
确定胃食管交界腺癌(GEJ)与食管下三分之一鳞状细胞癌(LTE)在生物化学方面是否存在根本差异。
1997年2月1日至2000年2月1日期间,我们在54例患者切除时获取组织样本进行生化分析。54例患者样本中有47例(81%)的全套数据可进行全面分析。其中,29例为GEJ腺癌,Siewert I型(n = 8)、II型(n = 12)、III型(n = 9),18例为LTE鳞状细胞癌。我们评估了肿瘤组织和周围黏膜中11种溶酶体酶和1种胞质蛋白酶的活性平均值及其相对活性,以同一患者肿瘤组织和正常组织活性之比来衡量。对这些数据进一步分析,以确定与肿瘤定位、TNM分期(淋巴结受累情况)、组织学类型(乳头状、印戒细胞、管状)、分化程度(高、中、低)及生存率(≤24个月或≥24个月)的相关性。
腺癌中,与正常胃黏膜相比,α-甘露糖苷酶(AMAN)、组织蛋白酶B(CB)和二肽基肽酶I(DPP I)的活性显著增加。在食管鳞状细胞癌中,除这三种酶外,我们还发现组织蛋白酶L和三肽基肽酶I的活性存在显著差异。GEJ腺癌的分化程度与AMAN、CB和DPP I活性之间存在统计学相关性,因为组织学证实无淋巴结转移的高分化肿瘤显示出显著较低的活性。CB和DPP I活性的差异与生存率差异密切相关,因为手术干预后24个月内死亡患者的CB和DPP I值显著高于存活2年或更长时间的患者。
从肿瘤生物化学角度来看,GEJ腺癌构成一个同质组,在许多方面与LTE鳞状细胞癌的生化特征不同。在术前检查GEJ腺癌时,肿瘤组织样本与距肿瘤2 cm内相邻完整黏膜的AMAN、CB和DPP I酶活性比值即使在术前检查阶段也可能具有预后价值,并可能表明应考虑将这些患者纳入新辅助治疗组。